Summary
The global Cough Suppressant Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Cough suppressant drugs are used to relieve the cough caused due to common cold, breathing illness, smoking, pneumonia, asthma, and bronchitis. It helps in thinning and loosening the mucus in the lung's airways and clear the congestion. Cough is a reflex action of foreign irritants in the throat and it can be classified into a dry cough and wet cough. Cough suppressant is also referred to as antitussives and they act by suppressing cough coordinating area in the brain. Congestion, chest pain, fever, and itchy throat are some of the common symptoms of cough.
Rising cases of asthma which is one of the major causes of cough is expected to propel the market growth of cough suppressant drugs. According to the World Health Organization, around 235 million people currently suffer from asthma each year. It is a common disease among children. A growing number of smokers around the globe are also expected to fuel the market growth of cough suppressant drugs. Additionally, growth in the pharmaceutical and healthcare industry is another major factor expected to foster the market growth of the cough suppressant drugs.
North America is expected to gain significant growth over the forecast period and this is attributed to the presence of a well-established healthcare industry coupled with the rising demand for herbal cough suppressant drug in the region. For instance, in November 2019, Pascoe Canada has expanded its product line of natural remedies for cough and cold, with Tussiflorin® Thyme, an herbal cough syrup. Tussiflorin® Thyme relieves both wet/chest coughs, as well as dry coughs, and even helps fight bronchitis.
Key Developments:
- In May 2018, iNova Pharmaceuticals has introduced a new product to their cough portfolio, adding to their well-established range of dry and wet cough relief options. Pholtex Plus is an effective formulation to relieve a dry cough and a blocked nose 2; common complaints associated with viral upper respiratory infections, Allergic rhinitis, and Post-nasal drip.
- In December 2018, Vernalis and Tris Pharma launched Tuzistra™ XR, extended-release oral suspension, CIII (DEA Schedule III) in the United States. Tuzistra™ XR, was approved by the U.S. Food and Drug Administration on April 30, 2015. It is indicated for the relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older.
The Cough Suppressant Drugs Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Cough Suppressant Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Perrigo Company
- Vernalis
- Tris Pharma
- Pfizer
- Acella Pharmaceuticals
- GlaxoSmithKline
- ...
By the Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
- Hospital
- Retail Pharmacy
- Online Pharmacy
- Others
The report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Cough Suppressant Drugs Market Report:
- To assess the size of the market by value and volume
- Analyze the Cough Suppressant Drugs Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Cough Suppressant Drugs Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact the growth of the Cough Suppressant Drugs Market
The Cough Suppressant Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Cough Suppressant Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type, and application, 2019 are considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into the specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Request Discount 
Inquire Before Buy
